Navigation Links
Paragon Bioservices to Partner and Exhibit at the 2011 BIO International Convention
Date:6/9/2011

BALTIMORE, June 9, 2011 /PRNewswire/ -- Paragon Bioservices, Inc., a Baltimore-based contract research and GMP manufacturing organization, announced today that representatives from the company will be participating in the 2011 BIO International Convention's One-on-One Partnering Meetings being held on June 27-30 in Washington, D.C. at the Walter E. Washington Convention Center.

Founded in 1990, Paragon Bioservices is a CMC Center of Excellence delivering research, development and cGMP manufacturing services to pharmaceutical companies, biotechnology companies and federal agencies. With a focus on vaccines (VLPs), monoclonal antibodies, therapeutic proteins and stem cells, Paragon's role is to bridge the translational divide and to enable vaccines—as well as proteins and cell-based therapeutics—to move from the research bench into Phase I/II clinical trials.

Representatives available to discuss Paragon's capabilities include: Dr. Marco Chacon, President & CEO; Jessica Boehmer, Director of Sales & Business Development; Dr. Philip Wills, Corporate Scientific Liaison; and Dr. Aaron Heifetz, Stem Cell & Regenerative Medicine.  Companies or individuals attending BIO 2011 can schedule meetings with Paragon by visiting: http://oneononepartnering.bio.org/BusinessForum2011/Login.aspx. Partnering Schedule:Monday, June 27Business Forum  -  12:00 p.m. – 5:00 p.m.Tuesday, June 28Business Forum  -  8:00 p.m. – 5:00 p.m.Wednesday, June 29Business Forum  -  8:00 a.m. – 5:00 p.m.Thursday, June 30Business Forum  -  8:00 a.m. – 5:00 p.m.For companies or individuals not participating in partnering meetings, Paragon will be exhibiting in booth number 1657 located in Hall A – BIO Process Zone.

About Paragon Bioservices, Inc.Located in Baltimore, Maryland, Paragon Bioservices is a privately held contract research and manufacturing organization (CMO) with a focus on the development and manufacturing of biopharmaceuticals—either for research purposes or clinical trials. Working as an outsourcing partner and with a long standing tradition of quality and service, Paragon expands the capabilities of pharmaceutical companies, biotechnology companies and government agencies involved in the development of monoclonal antibodies, therapeutic proteins, vaccines/VLPs and stem cells.

For more information visit: www.paragonbioservices.com.

Media Contacts:Tiberend Strategic Advisors, Inc.  (212) 827-0020
Tamara Bright tbright@tiberend.com or Claire Sojda csojda@tiberend.com


'/>"/>

SOURCE Paragon Bioservices, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Paragon Bioservices Launches Second Expansion to Celebrate its 20th Anniversary
2. ParagonRx Names Ellen M. Derrico To Chief Marketing Executive Post
3. Surgical Information Systems Partners with Siemens to Deliver Advanced Perioperative Solutions to Enterprise Health Information System Customers
4. COPAN Announces Strategic Global Distribution Partnership with Siemens
5. AmeriCares Honors AstraZeneca with Power of Partnership Award
6. Medco Partners With MolecularMD on Personalized Medicine Program for Chronic Myeloid Leukemia
7. University of Pennsylvania Announces Partnership with Chinese Academy of Sciences for Center of Excellence in Brain Mapping
8. Signal Genetics Announces Commercialization Partnership with NeoGenomics Laboratories for Multiple Myeloma Gene Expression Test
9. Vivo Ventures Announces Promotions of Dr. Chen Yu and Dr. James Zhao to Managing Partner
10. Aethlon Medical to Present the Aethlon ADAPT™ System at C21 BioVentures™ Life Sciences Partnering Conference
11. Exagen Diagnostics Inc. Partners with Medco Research Institute® to Develop NIMBLE Personalized Medicine Program for Rheumatoid Arthritis Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)...   Bernstein Liebhard LLP today announced that a ... District Court for the District of Arizona ... all persons or entities who purchased common shares of Insys ... from March 3, 2015 through January 25, 2016 (the "Class ... with violations of the Securities Exchange Act of 1934.  ...
(Date:2/4/2016)... 2016  Montoya Love is recognized by Continental Who,s ... Pharmaceuticals. Montoya is the Regulatory Systems Operations Manager with ... Manufacturing and selling a broad range ... provides healthcare institutions, clinical laboratories and life science researchers ... the globe. ...
(Date:2/4/2016)... -- Frontier Pharma: Chronic Obstructive Pulmonary Disease (COPD) ... Chronic Obstructive Pulmonary Disease (COPD) is a ... airways and lungs. Persistent breathing difficulties and repeated ... of the leading causes of morbidity and the ... is linked to cumulative exposure to risk factors, ...
Breaking Medicine Technology:
(Date:2/7/2016)... ... February 07, 2016 , ... HealthSmart Holdings, Inc. announced ... with the tools and information to lower the costs, and increase the impact ... of providing employee healthcare benefits by as much as 22%:, + Price ...
(Date:2/6/2016)... ... February 06, 2016 , ... ... PERIOPERATIVE NURSES EXPECTED AT AORN SURGICAL CONFERENCE & EXPO , WHAT:     , ... with an estimated 5000 perioperative nurses in attendance to study the latest ...
(Date:2/6/2016)... , ... February 06, 2016 , ... With the ... add warm color grades to their footage. A LUT is a Lookup Table that ... to the corresponding color indicated by the table. By manipulating each pixel, LUT's can ...
(Date:2/6/2016)... (PRWEB) , ... February 06, 2016 , ... ... phases of eating disorder treatment helps to reduce the frequency and level of ... the Recovery Phase: Re-Establishing Healthy Identity and Purpose,” will explore the critical tasks ...
(Date:2/5/2016)... NY (PRWEB) , ... February 05, 2016 , ... Love ... long-stem roses in a variety of colors, assortments and packaging. This staple for Valentine’s ... any King Kullen location. , For Valentine’s Day, not only are long-stem roses ...
Breaking Medicine News(10 mins):